How Do You Get Rid of Psoriasis on Your Scalp
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 11, 2021 Category: General Medicine Source Type: news

5:2 diet helps reduce skin symptoms in Psoriasis patients
(Say Communications) New research investigating for the first time the effects of modified intermittent fasting (MIF) on the skin of people with psoriasis has yielded promising results. Preliminary study findings presented today at the EADV Spring Symposium, show a significant reduction in scaling and thickness in patients with mild psoriasis after following a MIF 5:2 diet (eating normally for 5 days and restricting calorie intake on 2 non-consecutive days). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 6, 2021 Category: International Medicine & Public Health Source Type: news

Jab ends scaly skin misery for 60% of psoriasis patients
Libby Quayle, right, from Manchester, pictured with her friend Paiton Barker, has enrolled in a clinical trial to test the efficacy of the new psoriasis treatment bimekizumab. (Source: the Mail online | Health)
Source: the Mail online | Health - May 1, 2021 Category: Consumer Health News Source Type: news

TNFi Linked to Threefold Higher Psoriasis Risk in JIA Patients TNFi Linked to Threefold Higher Psoriasis Risk in JIA Patients
Although this study confirms earlier findings of an increased risk of psoriasis after TNF inhibitor exposure, it does not necessarily change the JIA management plan for most patients, an expert said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 29, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Studies Add to Knowledge Base of Biosimilars for Psoriasis, HS Studies Add to Knowledge Base of Biosimilars for Psoriasis, HS
The results add to mounting evidence that biosimilars may be interchangeable in certain dermatologic conditions.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 29, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Non-alcoholic fatty liver disease: Psoriasis is a risk factor - how to spot it on the skin
NON-ALCOHOLIC fatty liver disease is a serious condition that is usually symptomless. However, research suggests people with psoriasis are at a greater risk of NAFLD - what are the symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - April 28, 2021 Category: Consumer Health News Source Type: news

Study Finds Psoriasis Associated With an Increased COVID-19 Risk Study Finds Psoriasis Associated With an Increased COVID-19 Risk
In the study, some systemic treatments appeared to lower risk in patients, compared with those on topical therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 28, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Baseline Patient Characteristics May Predict Psoriasis Course
TUESDAY, April 27, 2021 -- Patient characteristics at onset can help to estimate the long-term course of psoriasis with good discriminatory power, according to a study published online April 14 in JAMA Dermatology. Axel Svedbom, from the Karolinska... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2021 Category: Pharmaceuticals Source Type: news

New Drug May Be Better Psoriasis Treatment
There was a "night and day difference" in the results from bimekizumab compared against two established psoriasis drugs. (Source: WebMD Health)
Source: WebMD Health - April 26, 2021 Category: Consumer Health News Source Type: news

Bimekizumab Tops Secukinumab for Plaque Psoriasis
MONDAY, April 26, 2021 -- For patients with moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to two studies published online April 23 in the New England Journal of Medicine to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2021 Category: Pharmaceuticals Source Type: news

New Drug May Be Better Psoriasis Treatment
MONDAY, April 26, 2021 -- A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials. There was a " night and day difference " in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2021 Category: General Medicine Source Type: news

New Drug May Be Better Psoriasis Treatment
Title: New Drug May Be Better Psoriasis TreatmentCategory: Health NewsCreated: 4/26/2021 12:00:00 AMLast Editorial Review: 4/26/2021 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - April 26, 2021 Category: Dermatology Source Type: news

Debate: Should Biologics Be Used for Milder Cases of Psoriasis? Debate: Should Biologics Be Used for Milder Cases of Psoriasis?
The remarkable efficacy of biologics for moderate-to-severe psoriasis has led some to ask if biologics should be used for milder cases.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 26, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab
At 4 months, 62% of those on bimekizumab had complete clearance.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 24, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Bimekizumab Tops Adalimumab for Plaque Psoriasis Bimekizumab Tops Adalimumab for Plaque Psoriasis
At week 16, 86.2% of those in the bimekizumab group had a PASI 90 response, compared with 47.2% in the adalimumab group.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 23, 2021 Category: Dermatology Tags: Dermatology News Source Type: news